Health plans and PBMs warn parity bill would raise premiums and create monopoly risk
Trade groups and PBMs told the Health and Human Services Committee that mandating parity for non‑opioid prescription alternatives risks immediate cost increases and concentrates leverage with single manufacturers while competition is limited.
The full story
Representatives of insurance plans and pharmacy benefit managers urged the House Health and Human Services Committee to oppose the parity bill now under consideration, saying it would impose measurable premium increases and could produce an effective monopoly in the short term.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or
Free account
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in